Frontiers in Aging Neuroscience has just published the second paper on Cognitive and Memory Deficits in Long COVID from The COVID and Cognition Study (COVCOG). Although COVID-19 has largely been considered a respiratory disease, study results have indicated that between 35% and 85 % of patients reported neurological symptoms including headache, dizziness, myalgia, or loss […]
Search Results for: COVID
Lyme in Prosthetic Joint Infections/Status of Lyme Disease/New Class of ABX/Gram-Negative TBD/Teasel/Pfizer Infant & Toddler COVID Vax/Lyme Vax Candidate/Seresto/Opossums/Dilution Host/W. Blacklegged
This article summarizes a review of literature regarding reported cases of prosthetic joint infections (PJI) caused by Lyme in knee replacements. The goal of the review was to initiate the development of a treatment strategy for these infections.
The FDA has just announced that they plan to postpone their scheduled advisory committee meeting on Pfizer’s COVID-19 vaccine for children ages 6 months to 4 years. They do not expect to reconvene for a few more months pending additional data required to move forward. A two-dose vaccine series failed to meet “immunobridging” criteria […]
Dr. Greg Bach/COVID & Lyme Brain/Persistent Symptoms/Brain Inflammation/Ivermectin/ABX Study/NYC Ticks/ABX Resistance/Anaplasma & As. Longhorned Tick/Babesiosis/W. Blacklegged Tick/Bill/Babesia/Guide
The Lyme Disease Association is sad to announce the death of Dr. Gregory P. Bach, a decades-long physician treating patients with Lyme & tick-borne diseases. Dr. Bach initially worked/trained with Lyme pioneer, clinician Dr. John Drulle, in New Jersey, and Dr. Bach then opened an office in Pennsylvania.
A new peer reviewed article was published in Cureus that evaluated the use of Ivermectin for prophylaxis of COVID 19 in a city-wide study conducted in Itajaí, Brazil. Study results showed that regular use of ivermectin as a prophylactic was associated with significantly reduced COVID-19 infection, hospitalization, and mortality rates. Authors reviewed studies suggesting Ivermectin has […]
A new writing in Science has been published, Nervous System Consequences of COVID 19. In this writing authors discuss an array of symptoms such as frequent headaches, intractable fatigue, sensory disturbances, autonomic dysfunction, depression, psychological impacts, and in severe cases, delusions and paranoia, that may persist for months after initial infection, now called Long COVID. […]
LDA-Columbia Lyme Conf. Videos/Help LDA/Bb in Alzheimer’s Brain/Tick Sugar/Columbia CTN/Bb in SD/Bait Boxes/ILADS Jumbotron/I. Scapularis & Lizards/AR Community Scientists/Hopkins Dashboard/COVID
LDA has released for public on LDA’s YouTube Channel, lectures from the LDA-Columbia 21 st Annual Lyme & Tick-borne Diseases 2021 CME Conference. See lectures by Drs. Aucott, Baranchuk, Breitschwerdt, Brissette, Ericson, Fallon, Lewis, Liegner, and Maggi.
New Lyme & TBD Pregnancy Treatments/21st Annual Lyme & TBD Conf. Completed/President’s Blog: Why Patients Need Gov. Investigation/TBD Risk for Transplant & Transfusion Recipients/Cognitive Impairment After COVID/LDA #GivingTuesday, Nov 6 thru Dec 6
In a recently published review article,* authors provide a comprehensive summary of treatment options for pregnant patients with less common bacterial, fungal, and viral infections, including several tick-borne diseases (Lyme disease, ehrlichiosis, human granulocytic anaplasmosis, human monocytic ehrlichiosis, babesiosis, and Rocky Mountain spotted fever). This review provides guidance to clinicians based on the most recently published evidence-based research and expert recommendations.
A study published in JAMA Network Open examined the cognitive function in patients following COVID-19 Infection. The researchers analyzed data from a cohort of COVID-19 patients from April 2020 through May 2021 and investigated rates of cognitive impairment in survivors who were treated in outpatient, emergency department, or inpatient hospital settings. Prior studies were hindered by limited sample sizes and substandard evaluation of cognitive functioning.
Ticks & Biowarfare Investigation Passes House/Last Chance to Register for LDA Conf. Before Price Increase/COVID Impacts on Lyme Reporting/Monoclonal Antibody COVID Treatment/LDA Doctor Referral Now Open/Valneva Lyme Vaccine
The Lyme Disease Association announces that the House voted this week to pass a number of amendments to the NDAA, National Defense Authorization Act, including a Congressman Chris Smith amendment.